Perrigo Confirms FDA Approval For Testosterone Gel 1%Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%.
Stem Cell Research Aims To Help Lou Gehrig's Patients Promising new research at the University of Michigan that could bring new hope to those suffering from Lou Gehrig's disease.
Perrigo Gets FDA Approval for OTC Allergy Syrup

More From CBS Detroit

Hump Day Drinks: 8 Cheery Cocktail RecipesNow that you've made it through half the work week, it's time to celebrate!
Daily J

Watch & Listen